What Cancer Is Blue? The Truth About Blue Skin Moles

No single cancer “owns” the color blue, but several skin cancers and precancerous growths can look distinctly blue or blue-gray to the naked eye. The lesion most closely associated with the color is the blue nevus, a usually benign mole whose pigment sits deep enough in the skin to scatter light in a way that reads as steel-blue or slate. When a true cancer does appear blue, the most likely culprits are melanoma arising within a blue nevus (sometimes called “malignant blue nevus”), pigmented basal cell carcinoma, or, less commonly, Kaposi sarcoma. The color itself is not a diagnosis, but it is a signal worth understanding.

Why Some Moles Look Blue in the First Place

Most moles are brown or tan because their melanin-producing cells sit near the skin’s surface, where the pigment absorbs and reflects light in familiar warm tones. In a blue nevus, those pigment cells live deeper, in the middle or lower layers of the dermis. For decades, dermatology textbooks attributed the blue color to the Tyndall effect, the same light-scattering phenomenon that makes the sky blue. A study published in JAMA Dermatology challenged that explanation, finding that both blue nevi and veins showed reflectance patterns consistent with ordinary melanin absorption rather than significant blue-light scattering. The shorter wavelengths around 400 to 500 nanometers reflected only about 8 percent off the skin surface, meaning scattering contributed very little. Instead, the amount of red-spectrum light getting absorbed was the main driver of the perceived blue color.

¹

In plain terms, the deep melanin soaks up most of the red and orange wavelengths before they bounce back to your eye, leaving the bluish tones to dominate what you see. The process is closer to subtractive color mixing, the way paint colors blend, than to the atmospheric scattering of the Tyndall effect. This matters because the same optical trick can make both harmless moles and dangerous cancers appear blue. Color alone does not separate the two.

The Common Blue Nevus and Its Variants

A blue nevus is, in the vast majority of cases, completely benign. It is a melanocytic lesion, meaning it originates from the same pigment-producing cells responsible for ordinary moles. The two most frequent variants are the dendritic (common) blue nevus and the cellular blue nevus.

²

The dendritic blue nevus is made up of elongated, spindle-shaped melanocytes with branching arms that hold melanin pigment. Under the microscope, these cells sit within the dermis and show almost no signs of abnormal growth: cell irregularity is minimal and dividing cells are almost never seen.

³

The cellular blue nevus is more complex. It tends to be larger and can extend deep into the fat layer beneath the skin. Under magnification, it contains plump spindle-shaped cells alongside the dendritic melanocytes seen in common blue nevi. There is often considerable variation in how cellular blue nevi look under the microscope, which can sometimes make them tricky for pathologists to distinguish from early melanoma. Despite that challenge, the cellular blue nevus is still considered benign, though some researchers have proposed it as a potential precursor to malignant change.

⁴

Clinically, a typical blue nevus is small, usually under a centimeter, well-defined, and stable over years. It can show up anywhere but tends to favor the scalp, face, hands, and feet. If you have had one for as long as you can remember and it has not changed, it is almost certainly nothing to worry about.

Melanoma Arising in a Blue Nevus

The condition most people are thinking of when they search “what cancer is blue” is melanoma arising in a blue nevus, sometimes labeled “malignant blue nevus.” It is rare but serious. A review of ten cases found that the head and neck, especially the scalp, was the most common location, and that most lesions had been present for many years before being removed. Tumor size averaged about 1.1 centimeters. Among the seven patients with follow-up data, all experienced either recurrence or metastasis, and three died of the disease.

⁵

That same review found that “malignant blue nevus” is actually a mixed group. Some cases were melanomas that arose within an existing benign blue nevus, where the transition from harmless to dangerous could be seen under the microscope as a distinct nodule of abnormal cells butting up against normal blue nevus tissue. Other cases were melanomas that developed on their own but happened to mimic the appearance of a cellular blue nevus, with no benign precursor visible at all. In all ten cases, the hallmarks of malignancy included a high rate of cell division, dead tissue within the tumor, abnormal nuclei, and visible variation in cell size and shape.

Molecularly, these melanomas are unusual. They carry a genetic profile closer to uveal melanoma, the cancer of the eye’s pigmented layer, than to the typical skin melanomas most people are familiar with. Researchers have found that GNAQ mutations, rather than the BRAF and NRAS mutations common in ordinary skin melanoma, are present in about 83 percent of blue nevi and about 46 percent of uveal melanomas.

⁶

This shared genetic pathway helps explain why melanomas arising in blue nevi behave differently from conventional cutaneous melanomas and can respond differently to targeted treatments.

⁷

The Blue-Black Rule for Nodular Melanoma

Blue coloring is not exclusive to blue nevi and their malignant cousins. Nodular melanoma, one of the more aggressive melanoma subtypes, often presents with blue or blue-black areas. This is one of the hardest melanomas to catch early because it tends to grow outward as a dome-shaped bump rather than spreading sideways the way most melanomas do, which means the familiar “ABCDE” checklist (asymmetry, border irregularity, color variation, diameter, evolving) can miss it.

A dermoscopic study found that a simple “blue-black rule” detected pigmented nodular melanoma with about 78 percent sensitivity, compared to roughly 44 percent sensitivity for standard diagnostic criteria alone. Combining the blue-black feature with the standard criteria pushed sensitivity to nearly 85 percent while maintaining about 81 percent specificity.

⁸

Patients themselves have reported blue or black coloring as one of the earliest signs they noticed before diagnosis. A qualitative study of patients with thin nodular melanoma found that blue, white, and black coloring, along with rapid changes in shape over as little as two weeks, were among the early warnings people recalled. Several described a gut feeling that the mole “did not feel right,” even before the color change was dramatic.

⁹

Pigmented Basal Cell Carcinoma

Basal cell carcinoma is the most common skin cancer, and while it usually appears as a pearly, flesh-colored, or pinkish bump, a pigmented subtype can look strikingly blue. Under dermoscopy, pigmented basal cell carcinomas show characteristic blue-gray ovoid nests, blue-gray globules, and sometimes spoke-wheel structures that are blue or gray.

¹⁰

A study examining hundreds of basal cell carcinomas found that blue-gray ovoid nests were present in roughly half of pigmented cases, and blue-gray globules appeared in about a quarter. Other hallmarks include arborizing (tree-branching) blood vessels and ulceration. Large blue-gray ovoid nests were among the most reliable diagnostic features for this type of cancer, along with the branching blood vessel pattern and leaf-shaped pigment areas.

¹¹

What helps distinguish pigmented basal cell carcinoma from a melanoma or blue nevus is the absence of a pigment network, the fine grid-like pattern that melanocytic lesions often display. If a dermatologist sees blue-gray nests plus branching blood vessels but no pigment network, basal cell carcinoma jumps to the top of the list.

¹²

When Melanoma Metastasizes and Looks Like a Blue Nevus

In rare cases, melanoma that has spread from a primary tumor elsewhere in the body can deposit in the skin and mimic the appearance of a harmless blue nevus. These blue nevus-like metastatic melanomas are exceptionally uncommon but diagnostically dangerous, because the metastatic cells can show minimal irregularity under the microscope, making them easy to mistake for an ordinary mole.

¹³

In one reported case, a metastatic melanoma with features resembling a blue nevus was identified during immunotherapy treatment. The histologic appearance closely mimicked a common blue nevus, exhibiting little of the aggressive-looking cell variation pathologists usually rely on to flag a metastasis.

¹⁴

The practical takeaway here is for people with a history of melanoma. If a new blue-colored spot appears on your skin after a melanoma diagnosis, your dermatologist will likely biopsy it even if it looks perfectly innocent. Context matters as much as appearance.

Kaposi Sarcoma and Vascular Mimics

Kaposi sarcoma is a cancer that arises from the cells lining blood and lymph vessels. It typically presents as purple or violaceous lesions on the skin, but these can shade into dark blue, especially in people with darker skin tones. Kaposi sarcoma is most commonly associated with HIV/AIDS, where it occurs across all transmission groups but at especially high rates among men who have sex with men. It can affect the skin, oral mucosa, lymph nodes, and internal organs.

¹⁵

Separate from cancer, a rare vascular condition called blue rubber bleb nevus syndrome can produce deep-blue, soft, compressible blebs on the skin. These are venous malformations, not tumors, but they can look alarming. The lesions also appear in the gastrointestinal tract, where they can cause bleeding. Despite the word “nevus” in the name, these are not melanocytic lesions at all. Historically they were misclassified as hemangiomas, which added to the confusion.

¹⁶

How Dermoscopy Helps Sort Blue Lesions

When you visit a dermatologist for a blue spot, one of the first things they will do is look at it through a dermatoscope, a handheld device that magnifies and illuminates the skin. Blue nevi have a characteristic appearance under dermoscopy: a uniform, structureless, blue to blue-black patch. In a study of 95 blue nevi, every single one displayed homogeneous pigmentation as its global pattern. About 84 percent showed one or two colors, most often blue combined with brown, gray, or black. Roughly half had no additional structural features at all, just a smooth, even field of color.

¹⁷

That uniformity is itself a reassuring sign. Melanomas tend to show multiple colors, irregular dots or streaks, and asymmetric patterns. A blue lesion that is perfectly even in color and has no structural quirks is far more likely to be a benign blue nevus. However, about 16 percent of blue nevi in that same study showed multicolored patterns with red, brown, or gray mixed in, which can raise suspicion and lead to a biopsy.

Some blue nevi can even show a starburst pattern, radial streaks projecting outward, a feature more commonly associated with Spitz nevi or melanoma. Case reports document this variant and emphasize that dermoscopy alone sometimes cannot settle the diagnosis.

¹⁸

Biopsy and the Challenge of Telling Benign From Malignant

When dermoscopy leaves doubt, a biopsy is the next step. Current guidelines from the Children’s Oncology Group recommend excisional biopsies with 1 to 3 millimeter margins for clinically suspicious melanocytic lesions whenever feasible, and more advanced tools including immunohistochemistry and next-generation sequencing when classification remains uncertain.

¹⁹

Under the microscope, pathologists face a genuine challenge with blue lesions. Both common and cellular blue nevi react to HMB-45, an antibody that was once thought to be specific to melanoma. In one study, 14 out of 16 common blue nevi and all 6 cellular blue nevi tested positive for HMB-45, meaning this marker alone cannot separate benign from malignant.

²⁰

Newer research has focused on BAP-1, a tumor-suppressor protein. In a small series, loss of BAP-1 expression was seen in three out of four melanomas arising in or mimicking blue nevi, compared to only one out of eleven benign blue nevi. That pattern is promising but imperfect. The fact that one benign case lost BAP-1 and one malignant case kept it means the marker is helpful but not a standalone test.

²¹

This diagnostic gray zone is one reason dermatologists sometimes recommend removing a stable blue nevus that a patient has had for years: if there is any clinical suspicion, getting it examined under the microscope is the only way to be certain.

Blue Spots in Children and Mongolian Spots

Parents sometimes discover blue or blue-gray patches on their infant’s skin and worry about cancer. In the vast majority of cases, these are dermal melanocytoses, commonly known as Mongolian spots, areas of deep melanin deposition that appear most often on the lower back and buttocks. They are extremely common in babies with darker skin tones and usually fade on their own within the first few years of life.

Mongolian spots are not moles and carry no cancer risk. However, when they appear in unusual locations, such as the face, arms, or legs, or when they are unusually extensive and persistent, they can occasionally signal an underlying genetic condition. A review found that persistent and widespread Mongolian spots have been associated with lysosomal storage diseases and a condition called phakomatosis pigmentovascularis.

²²

True blue nevi in children do occur but are uncommon. When they do appear, they warrant the same dermoscopic evaluation as in adults. The pediatric context also brings up the epithelioid blue nevus, a rare variant originally described in patients with Carney complex, a genetic syndrome involving skin pigmentation abnormalities, heart tumors, and endocrine overactivity. Researchers have since found that epithelioid blue nevi can also appear as isolated, sporadic lesions in people with no sign of Carney complex.

²³

Drug-Induced Blue Skin Discoloration

Not every blue spot on the skin comes from melanocytes or cancer. Certain medications can cause blue or blue-gray discoloration of the skin and mucous membranes. Amiodarone, a heart rhythm drug, and minocycline, an antibiotic, are among the better-known culprits. More recently, ezogabine (retigabine), an anticonvulsant, was linked to blue-gray mucocutaneous discoloration. In reported cases, an extensive workup ruled out genetic, metabolic, and endocrine causes as well as metal ion deposits, leaving the drug itself as the most likely explanation.

²⁴

Silver exposure, known as argyria, produces a permanent blue-gray skin tone that can be dramatic. The discoloration is cosmetically distressing but not itself dangerous. Recognizing drug- or chemical-induced blue skin is important because it prevents unnecessary biopsies and avoids misdiagnosis as a melanocytic or vascular lesion. If you are taking a medication known to cause skin color changes and notice new blue-gray patches, mention it to your doctor before jumping to cancer concerns.